CodeMap® Compliance Briefing: March 30, 2012
The number of labs that are dedicated to performing drug determinations has skyrocketed in recent years. The demand for both qualitative and quantitative testing of drugs is fueled by the ever-increasing number of pain medications developed by the pharmaceutical industry, the willingness of physicians to prescribe pain medications, the tremendous increase in physician practices focused on pain management, and in some areas of the country state and local regulatory requirements. An examination of Medicare utilization data from 2008 through 2011 demonstrates that the Medicare program alone has experienced a 250% increase in reimbursements for quantitative drug determinations for both illicit and therapeutic drugs. The number of....
Sorry, the full document you are trying to access requires an active subscription.
Please login to the left.